ReviewBMC urology2025
Clear cell renal cell carcinoma with collecting duct carcinoma transformation: a case report and review of the literature.
Review in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Collecting duct carcinoma (CDC), a rare and aggressive renal malignancy originating from the medullary collecting ducts, often presents with nonspecific symptoms and rapid metastatic progression, yielding a dismal prognosis. The occurrence of a composite CDC and conventional renal cell carcinoma is rare in the literature. We report a 55-year-old female with clear cell renal cell carcinoma with collecting duct carcinoma transformation in the same kidney. Seven months postoperatively, the patient developed metastasis to the lungs. A literature review of 18 mixed CDC with other tumors highlights metastatic propensity (52% cases) and poor outcomes, emphasizing the need for molecular profiling to guide targeted therapies. This report contributes to the growing body of literature regarding the complexity of composite renal malignancies, furthering our understanding of clinical, imaging, and histological findings of this rare phenomenon.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.